Kutlu, Ö.; Günenç, D.; Ayaz, D.; Özdemir, Ö.; Taşkaynatan, H.; Akdemir, C.; Sancı, M.
Claudin-4 Overexpression Predicts Poor Survival and Platinum Resistance in Epithelial Ovarian Cancer: A Potential Biomarker for Clinical Decision-Making. Diagnostics 2025, 15, 3163.
https://doi.org/10.3390/diagnostics15243163
AMA Style
Kutlu Ö, Günenç D, Ayaz D, Özdemir Ö, Taşkaynatan H, Akdemir C, Sancı M.
Claudin-4 Overexpression Predicts Poor Survival and Platinum Resistance in Epithelial Ovarian Cancer: A Potential Biomarker for Clinical Decision-Making. Diagnostics. 2025; 15(24):3163.
https://doi.org/10.3390/diagnostics15243163
Chicago/Turabian Style
Kutlu, Özlem, Damla Günenç, Duygu Ayaz, Özlem Özdemir, Halil Taşkaynatan, Celal Akdemir, and Muzaffer Sancı.
2025. "Claudin-4 Overexpression Predicts Poor Survival and Platinum Resistance in Epithelial Ovarian Cancer: A Potential Biomarker for Clinical Decision-Making" Diagnostics 15, no. 24: 3163.
https://doi.org/10.3390/diagnostics15243163
APA Style
Kutlu, Ö., Günenç, D., Ayaz, D., Özdemir, Ö., Taşkaynatan, H., Akdemir, C., & Sancı, M.
(2025). Claudin-4 Overexpression Predicts Poor Survival and Platinum Resistance in Epithelial Ovarian Cancer: A Potential Biomarker for Clinical Decision-Making. Diagnostics, 15(24), 3163.
https://doi.org/10.3390/diagnostics15243163
